ReviewNature protocols2026
Tutorial: strategies for targeting organelles using nanoparticles.
Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dysfunctions in specific subcellular organelles are fundamentally implicated in the pathogenesis of a wide range of critical diseases. Targeting these organelles has thus emerged as a promising strategy for achieving precise diagnostics and effective therapies. Nanotechnology serves as a powerful platform in this endeavor, enabling the rational design of nanoparticles with tailored physicochemical properties to control their intracellular trafficking and localization. This Tutorial systematically examines design strategies for nanoparticles that target key organelles, including mitochondria, lysosomes, the nucleus, the endoplasmic reticulum and the Golgi apparatus. Here we summarize organelle-specific targeting design strategies, elucidate the underlying fundamental principles and describe experimental methodologies for validating subcellular localization. Furthermore, we discuss emerging frontiers in the field. We aim to provide a systematic and actionable guide for researchers in materials science, chemistry, biology and medicine, supporting the development of next-generation organelle-targeted nanomedicines for both fundamental research and translational applications.
Identifiers
42420644What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.